Numerous studies have revealed that elevated serum YKL‐40 is associated with disease severity, which may correspond to poor prognosis in many diseases, including cancer, type 2 diabetes, and coronary artery disease [23, 24, 25]. The gene discussed is CHI3L1; the disease is cancer.